Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31095442 | 0.86 | PARP1 (0.32) | — | |
| SCHEMBL2565987 | 0.85 | ALDH1A1 (0.33) | ALDH1A1KDM4EGAAMAPTL3MBTL1 | |
| SCHEMBL4668404 | 0.82 | — | — | |
| SCHEMBL14844780 | 0.80 | KDM4E (0.31) | KDM4E | |
| SCHEMBL230414 | 0.77 | KDM4E (0.50) | ALDH1A1KDM4EGAAMAPTL3MBTL1 | |
| SCHEMBL163147 | 0.75 | GAA (0.38) | ALDH1A1KDM4EGAAMAPTL3MBTL1 | |
| SCHEMBL15226755 | 0.74 | MAPT (0.35) | ALDH1A1KDM4EGAAMAPTL3MBTL1 | |
| SCHEMBL162659 | 0.72 | ALDH1A1 (0.35) | ALDH1A1KDM4EGAAMAPTL3MBTL1 | |
| SCHEMBL16702912 | 0.71 | DRD2 (0.31) | — | |
| SCHEMBL2890469 | 0.68 | CHRNA1 (0.32) | ALDH1A1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12083100-B1 | Antiparasitic isoxazoline compounds, long-acting injectable formulations comprising them, methods and uses thereof | Boehringer Ingelheim Animal Health USA Inc. (US) | 2024-09-10 | — | — | US | disclosed |
| EP-2699563-B3 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2024-06-12 | — | — | EP | disclosed |
| EP-2699563-B1 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2016-04-06 | — | — | EP | disclosed |
| EP-2004635-B1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER IP GMBH (DE) | 2015-09-23 | — | — | EP | disclosed |
| EP-2327304-B1 | Use of substituted enaminocarbonyl compounds for combating animal pests | BAYER CROPSCIENCE AG (DE) | 2014-08-06 | — | — | EP | disclosed |
| EP-2699563-A1 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2014-02-26 | — | — | EP | disclosed |
| EP-2595981-A1 | NOVEL HETARYL (THIO)CARBOXAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | BASF SE (DE) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012150550-A1 | NOVEL PESTICIDAL AMINO PYRANONE COMPOUNDS | BASF SE (DE) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012143317-A1 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2012-10-26 | — | — | WO | disclosed |
| WO-2012010534-A1 | NOVEL HETARYL (THIO)CARBOXAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | BASF SE (DE) | 2012-01-26 | — | — | WO | disclosed |
| EP-2327304-A1 | Use of substituted enaminocarbonyl compounds for combating animal pests | Bayer CropScience AG (DE) | 2011-06-01 | — | — | EP | disclosed |
| EP-2004635-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | Bayer CropScience AG (DE) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007115644-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12083100-B1 | Antiparasitic isoxazoline compounds, long-acting injectable formulations comprising them, methods and uses thereof | IL17A, MMP17, MMP1 | ALDH1A1 2913/4885FFAR2 1364/4885KDM4E 3276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.